facebook linkedin twitter

Pfizer Vaccine for Kids May Not Be Available Until November

September 29, 2021by Jonathan Lemire, Associated Press
A certified medical assistant prepares doses of the Pfizer COVID-19 vaccine at a vaccination center at the University of Nevada, Las Vegas. (AP Photo/John Locher)

WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.

The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. Officials had said previously they would file an application with the FDA to authorize use in the coming weeks.

Once the company files its application, U.S. regulators and public health officials will review the evidence and consult with their advisory committees in public meetings to determine if the shots are safe and effective enough to recommend use. 

That process may mean the shots may not be available until closer to Thanksgiving, according to a person familiar with the process but not authorized to discuss it publicly. But it is possible that, depending on how quickly the FDA acts, the shots could become available earlier in November, the person said.

The drugmaker and its partner, Germany’s BioNTech, say they expect to request emergency use authorization of their vaccine in children ages 5 to 11 “in the coming weeks.” The companies also plan to submit data to the European Medicines Agency and other regulators.

The two-shot Pfizer vaccine is currently available for those 12 and older. An estimated 100 million people in the U.S. have been fully vaccinated with it, according to the Centers for Disease Control and Prevention.

Pfizer tested a lower dose of the shots in children. The drugmaker said last week that researchers found the vaccine developed coronavirus-fighting antibody levels in children that were just as strong as those found in teenagers and young adults getting regular-strength doses.

Earlier this month, FDA chief Dr. Peter Marks told the AP that once Pfizer turns over its study results, his agency would evaluate the data “hopefully in a matter of weeks” to decide if the shots are safe and effective enough for younger kids.

Pfizer’s updated timetable was first reported by The Wall Street Journal.

Another U.S. vaccine maker, Moderna, also is studying its shots in elementary school-aged children. Results are expected later in the year.

A+
a-

Health

December 5, 2021
by Dan McCue
Dobbs Now Supreme Court’s Most Anticipated Decision In Years

WASHINGTON — It wasn’t even the top headline in The New York Times the day after the decision was announced.... Read More

WASHINGTON — It wasn’t even the top headline in The New York Times the day after the decision was announced. That distinction went to the death of former President Lyndon Baines Johnson, who had died at age 64 after suffering a heart attack at his ranch... Read More

Omicron May Be Driving South Africa's Surge; Wary World Watches

JOHANNESBURG (AP) — Dr. Sikhulile Moyo was analyzing COVID-19 samples in his lab in Botswana last week when he noticed... Read More

JOHANNESBURG (AP) — Dr. Sikhulile Moyo was analyzing COVID-19 samples in his lab in Botswana last week when he noticed they looked startlingly different from others. Within days, the world was ablaze with the news that the coronavirus had a new variant of concern, which appears to be... Read More

EPA Head Tours Embattled Communities, Says Help On the Way

RESERVE, La. (AP) — Michael Coleman's house is the last one standing on his tiny street, squeezed between a sprawling... Read More

RESERVE, La. (AP) — Michael Coleman's house is the last one standing on his tiny street, squeezed between a sprawling oil refinery whose sounds and smells keep him up at night and a massive grain elevator that covers his pickup in dust and, he says, exacerbates... Read More

December 2, 2021
by Dan McCue
White House to Roll Out Comprehensive Plan for Winter COVID Response

WASHINGTON — President Joe Biden is set to roll out a comprehensive plan Monday to step up the nation’s fight... Read More

WASHINGTON — President Joe Biden is set to roll out a comprehensive plan Monday to step up the nation’s fight against the COVID-19 pandemic over the winter months. The moves, which will be announced during a visit to the National Institutes of Health Monday afternoon, come... Read More

December 2, 2021
by Alexa Hornbeck
Researchers Find That a Blood Test Can Help Diagnose Mood Disorders

Researchers from the Indiana University School of Medicine completed a recent study on how blood biomarkers can help diagnose and... Read More

Researchers from the Indiana University School of Medicine completed a recent study on how blood biomarkers can help diagnose and treat mood disorders. “The tests are now being made available to interested doctors through a company I co-founded, called MindX Sciences,” said psychiatrist, geneticist and lead... Read More

December 2, 2021
by Alexa Hornbeck
Stanford Physicians Launch Office of Child Health Equity

A team of researchers at Stanford Medicine’s Department of Pediatrics recently launched the Office of Child Health Equity to act... Read More

A team of researchers at Stanford Medicine’s Department of Pediatrics recently launched the Office of Child Health Equity to act as a unified force across pediatric departments and push for changes in California laws and regulations related to child health. Before the Office of Child Health... Read More

News From The Well
scroll top